Mark Gregory Bearman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3240 Edwards Lake Pkwy, Ste 100, Birmingham, AL 35235 Phone: 205-949-2020 Fax: 205-949-1400 |
Dr. David Abram Skier, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1830 14th Avenue South, Birmingham, AL 35205 Phone: 205-933-8273 Fax: 205-933-8277 |
Kristen Marie Peterson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1720 University Blvd Ste 601, Birmingham, AL 35233 Phone: 205-325-8507 |
Kristin Berlin Madonia, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 250 State Farm Pkwy, Birmingham, AL 35209 Phone: 205-943-4600 Fax: 205-943-4660 |
Martin Steven Cogen, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 |
Dr. Sarah Jablecki Hays, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: One West Lakeshore Drive, Suite 220, Birmingham, AL 35209 Phone: 205-941-2020 Fax: 205-397-4190 |
Robert Tauscher, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1720 University Blvd, Birmingham, AL 35233 Phone: 630-945-7755 |
John Skelton Owen Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Independence Plz, Ste. 700, Birmingham, AL 35209 Phone: 205-250-6042 Fax: 205-250-8944 |
News Archive
ADHD may be caused by alterations in the serotonin neurotransmission system combined with a tendency to experience psychosocial distress. Researchers writing in BioMed Central's open access journal Behavioral and Brain Functions found that ADHD behaviors in children and adolescents were associated with interactions between low and high serotonin activity and self-blame in relation to inter-parental conflict.
It's the comparative silence between the firing spikes of neurons that tells what they are really up to, scientists report.
A scoping review of studies on game interventions for cardiovascular diseaseself-management found that the use of digital games improved exercise capacity and energy expenditure significantly.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.
PTC Therapeutics, Inc. today announced that final analyses of Phase 2b efficacy data suggest the investigational new drug ataluren slowed the loss of walking ability in patients with nonsense mutation dystrophinopathy, a disease continuum comprising Duchenne and Becker muscular dystrophy (nmDBMD). These data were presented at the International Congress of the World Muscle Society in Kumamoto, Japan and will be the basis of interactions with the U.S. Food and Drug Administration (FDA) and national regulatory authorities in Europe in the fourth quarter of 2010.
› Verified 9 days ago